Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepatitis B Virus (HBV) Antibody (Anti-HBs) Booster Program for the Production of Hepatitis B Immune Globulin (HBIG)

NCT01311674 is registered in ClinicalTrials.gov with Emergent BioSolutions as lead sponsor.

NCT NCT01311674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01311674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepatitis B Virus (HBV) Antibody (Anti-HBs) Booster Program for the Production of Hepatitis B Immune Globulin (HBIG)
Lead sponsor
Emergent BioSolutions
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2009
Completion date
March 11, 2011
Enrollment
141 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers